Document is current
Any future updates will be listed below
-
Authors
Yorgancıoğlu, Arzu
Aksu, Kurtuluş
Cura, Ceyhun
Yaman, Yiğit
Dinç, Melda
Malhan, Simten
,
Kızılırmak, Deniz
Altıntaş, Nejat
Bulut, İsmet
Çağatay, Tülin
Gemicioğlu, Bilun
İnce, Özgür
Oğuzülgen, Kıvılcım
Mungan, Dilşad
Kalpaklıoğlu, Füsun
Baççıoğlu, Ayşe
Aksu, Funda
Altuntaş, Murat
Erkekol, Ferda Öner
Karakaya, Gül
Kalyoncu, Ali Fuat
Damadoğlu, Ebru
Hanta, İsmail
Altunok, Ersoy
Özer, Adviye
Naycı, Sibel Atış
Yuluğ, Demet Polat
Gülbaş, Gazi
Süerdem, Mecit
Yormaz, Burcu
Ceylan, Emel
Erge, Duygu
Çilli, Aykut
Doğan, Berat Celil
Erel, Fuat
Sevinç, Can
Anar, Ceyda
Ediger, Dane
Pekbak, Gülseren
Erbay, Müge
-
Funding
Funding for this research was provided by:
AstraZeneca Türkiye
- License Information
-
More Information
Article History
Received: 7 December 2023
Accepted: 4 October 2024
First Online: 21 October 2024
Declarations
:
: Ethical approval was not required for this cost-analysis study, using the datasets already generated in the previously published SABINA Türkiye study which was approved by Manisa Celal Bayar University Ethics Committee (Date of Approval: 06/08/2019, Protocol No: E.46053) and Republic of Turkey Ministry of Health Turkish Medicines and Medical Devices Agency (Date of Approval: 20/08/2019, Protocol No: 66175679–514.05.01-E.127964).
: Not applicable.
: AY has received research grants from MSD, AstraZeneca and Sanofi as a principal investigator/collaborator, received honoraria from AstraZeneca, Abdi İbrahim, GSK, Novartis Sandoz, Sanofi and Chiesi, and served as a consultant/advisory member for AstraZeneca, GSK, Novartis, Sanofi, Chiesi and Deva; KA has received research support from Sanofi, AstraZeneca, Health Institutes of Türkiye (TUSEB) and received consulting or scientific speaking fees from AstraZeneca, GlaxoSmithKline, Novartis, Sandoz, Chiesi, İbrahim Etem, Abdi İbrahim, Deva and Acino; CC is an employee of AstraZeneca Türkiye; YY is an employee of AstraZeneca Türkiye; MD is an employee of AstraZeneca Türkiye; SM has received research grants from AstraZeneca.
